Norihiko Kato

Summary

Country: Japan

Publications

  1. doi request reprint Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33
    Yasunori Kageyama
    Faculty of Health Sciences, Hamamatsu University, 1230 Miyakoda cho, Kita ku, Hamamatsu, Shizuoka 431 2102, Japan
    Mod Rheumatol 22:89-93. 2012
  2. doi request reprint Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Heisei Memorial Hospital, 123 1 Mizugami, Fujieda, 426 8662, Japan
    Mod Rheumatol 19:657-62. 2009
  3. doi request reprint Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Heisei Memorial Hospital, 123 1 Mizugami, Fujieda 426 8662, Japan
    Mod Rheumatol 19:372-8. 2009
  4. doi request reprint Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis
    Kageyama Yasunori
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Clin Rheumatol 27:1093-101. 2008
  5. ncbi request reprint Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis
    Y Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Clin Exp Rheumatol 26:73-80. 2008
  6. ncbi request reprint Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, 431 3125, Japan
    Mod Rheumatol 17:398-402. 2007
  7. ncbi request reprint Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Handayama, Hamamatsu, Japan
    Rheumatol Int 28:245-51. 2008
  8. ncbi request reprint Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Rheumatol Int 28:137-43. 2007
  9. ncbi request reprint Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Japan
    Rheumatol Int 27:467-72. 2007
  10. ncbi request reprint Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu 431 3125, Japan
    Clin Rheumatol 26:505-9. 2007

Collaborators

Detail Information

Publications12

  1. doi request reprint Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33
    Yasunori Kageyama
    Faculty of Health Sciences, Hamamatsu University, 1230 Miyakoda cho, Kita ku, Hamamatsu, Shizuoka 431 2102, Japan
    Mod Rheumatol 22:89-93. 2012
    ..These findings indicated that the decrease of serum IL-33 levels was a novel function of etanercept, shown for the first time in this study. Measurement of serum levels of IL-33 may become a useful control marker for RA treatment...
  2. doi request reprint Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Heisei Memorial Hospital, 123 1 Mizugami, Fujieda, 426 8662, Japan
    Mod Rheumatol 19:657-62. 2009
    ..This study indicated that the reduction of serum IL-23 levels in RA patients was a novel action of infliximab...
  3. doi request reprint Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Heisei Memorial Hospital, 123 1 Mizugami, Fujieda 426 8662, Japan
    Mod Rheumatol 19:372-8. 2009
    ..This study demonstrated that a reduction of MCP-1 production in RA patients was a newly determined effect of etanercept. Another cascade not associated with TNF-alpha may induce granzyme B and RANTES production in RA patients...
  4. doi request reprint Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis
    Kageyama Yasunori
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Clin Rheumatol 27:1093-101. 2008
    ..Etanercept may have the ability to reduce the levels of bone resorption markers and to increase the levels of a bone formation marker while reducing sRANKL formation in RA patients...
  5. ncbi request reprint Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis
    Y Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Clin Exp Rheumatol 26:73-80. 2008
    ..The aim of this study was to evaluate the effects of anti-TNF-alpha antibody, infliximab, on oxidative stress markers representing DNA damage, lipid peroxidation, and glycoxidation...
  6. ncbi request reprint Methotrexate reduces the levels of pentosidine and 8-hydroxy-deoxy guanosine in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu, 431 3125, Japan
    Mod Rheumatol 17:398-402. 2007
    ..Urinary 8-OHdG levels also were significantly reduced at 6 months after the initial treatment with MTX. This study demonstrated that MTX plays a role as a regulator against pentosidine formation and oxidative DNA damage in RA patients...
  7. ncbi request reprint Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Handayama, Hamamatsu, Japan
    Rheumatol Int 28:245-51. 2008
    ..This study demonstrated that etanercept acts as a regulator against pentosidine formation, oxidative DNA damage, and lipid peroxidation in RA patients...
  8. ncbi request reprint Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Rheumatol Int 28:137-43. 2007
    ..This study demonstrated that the reduction of IL-23 and MIP-3alpha production in RA patients was a newly determined function of etanercept...
  9. ncbi request reprint Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, Japan
    Rheumatol Int 27:467-72. 2007
    ..Infliximab treatment significantly lowered the serum levels of CXCL16 in patients with RA. CXCL16 is one of the crucial chemokines regulated by infliximab treatment...
  10. ncbi request reprint Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Department of Orthopaedic Surgery, Hamamatsu University School of Medicine, 1 20 1 Handayama, Hamamatsu 431 3125, Japan
    Clin Rheumatol 26:505-9. 2007
    ..Infliximab treatment significantly lowered the serum levels of IL-15 in patients with RA. IL-15 is one of the crucial cytokines affected by infliximab...
  11. ncbi request reprint Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis
    Yasunori Kageyama
    Departmentof Orthopaedic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
    Arthritis Rheum 50:968-75. 2004
    ..To evaluate the therapeutic effect of the administration of plasmid encoding interleukin-4 (IL-4) via gene-gun delivery and via intradermal injection on collagen-induced arthritis (CIA)...
  12. doi request reprint Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis
    Tetsuya Ichikawa
    Department of Orthopaedic Surgery, Narita Memorial Hospital, 78 Shirakawa cho, Toyohashi, 441 8021, Japan
    Rheumatol Int 30:725-30. 2010
    ..TNF-alpha induced production of IP-10, but not IL-15 in cultured synovial cells from RA patients. This study demonstrated for the first time the reduction of IP-10 and IL-15 production in RA patients as active mechanisms of etanercept...